Cargando…

Therapeutic potential of TRPM8 channels in cancer treatment

Cancer is a multifactorial process associated with changes in signaling pathways leading to cell cycle variations and gene expression. The transient receptor potential melastatin 8 (TRPM8) channel is a non-selective cation channel expressed in neuronal and non-neuronal tissues, where it is involved...

Descripción completa

Detalles Bibliográficos
Autores principales: Ochoa, Sara V., Casas, Zulma, Albarracín, Sonia L., Sutachan, Jhon Jairo, Torres, Yolima P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10073478/
https://www.ncbi.nlm.nih.gov/pubmed/37033630
http://dx.doi.org/10.3389/fphar.2023.1098448
_version_ 1785019575405903872
author Ochoa, Sara V.
Casas, Zulma
Albarracín, Sonia L.
Sutachan, Jhon Jairo
Torres, Yolima P.
author_facet Ochoa, Sara V.
Casas, Zulma
Albarracín, Sonia L.
Sutachan, Jhon Jairo
Torres, Yolima P.
author_sort Ochoa, Sara V.
collection PubMed
description Cancer is a multifactorial process associated with changes in signaling pathways leading to cell cycle variations and gene expression. The transient receptor potential melastatin 8 (TRPM8) channel is a non-selective cation channel expressed in neuronal and non-neuronal tissues, where it is involved in several processes, including thermosensation, differentiation, and migration. Cancer is a multifactorial process associated with changes in signaling pathways leading to variations in cell cycle and gene expression. Interestingly, it has been shown that TRPM8 channels also participate in physiological processes related to cancer, such as proliferation, survival, and invasion. For instance, TRPM8 channels have an important role in the diagnosis, prognosis, and treatment of prostate cancer. In addition, it has been reported that TRPM8 channels are involved in the progress of pancreatic, breast, bladder, colon, gastric, and skin cancers, glioblastoma, and neuroblastoma. In this review, we summarize the current knowledge on the role of TRPM8 channels in cancer progression. We also discuss the therapeutic potential of TRPM8 in carcinogenesis, which has been proposed as a molecular target for cancer therapy.
format Online
Article
Text
id pubmed-10073478
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-100734782023-04-06 Therapeutic potential of TRPM8 channels in cancer treatment Ochoa, Sara V. Casas, Zulma Albarracín, Sonia L. Sutachan, Jhon Jairo Torres, Yolima P. Front Pharmacol Pharmacology Cancer is a multifactorial process associated with changes in signaling pathways leading to cell cycle variations and gene expression. The transient receptor potential melastatin 8 (TRPM8) channel is a non-selective cation channel expressed in neuronal and non-neuronal tissues, where it is involved in several processes, including thermosensation, differentiation, and migration. Cancer is a multifactorial process associated with changes in signaling pathways leading to variations in cell cycle and gene expression. Interestingly, it has been shown that TRPM8 channels also participate in physiological processes related to cancer, such as proliferation, survival, and invasion. For instance, TRPM8 channels have an important role in the diagnosis, prognosis, and treatment of prostate cancer. In addition, it has been reported that TRPM8 channels are involved in the progress of pancreatic, breast, bladder, colon, gastric, and skin cancers, glioblastoma, and neuroblastoma. In this review, we summarize the current knowledge on the role of TRPM8 channels in cancer progression. We also discuss the therapeutic potential of TRPM8 in carcinogenesis, which has been proposed as a molecular target for cancer therapy. Frontiers Media S.A. 2023-03-22 /pmc/articles/PMC10073478/ /pubmed/37033630 http://dx.doi.org/10.3389/fphar.2023.1098448 Text en Copyright © 2023 Ochoa, Casas, Albarracín, Sutachan and Torres. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Pharmacology
Ochoa, Sara V.
Casas, Zulma
Albarracín, Sonia L.
Sutachan, Jhon Jairo
Torres, Yolima P.
Therapeutic potential of TRPM8 channels in cancer treatment
title Therapeutic potential of TRPM8 channels in cancer treatment
title_full Therapeutic potential of TRPM8 channels in cancer treatment
title_fullStr Therapeutic potential of TRPM8 channels in cancer treatment
title_full_unstemmed Therapeutic potential of TRPM8 channels in cancer treatment
title_short Therapeutic potential of TRPM8 channels in cancer treatment
title_sort therapeutic potential of trpm8 channels in cancer treatment
topic Pharmacology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10073478/
https://www.ncbi.nlm.nih.gov/pubmed/37033630
http://dx.doi.org/10.3389/fphar.2023.1098448
work_keys_str_mv AT ochoasarav therapeuticpotentialoftrpm8channelsincancertreatment
AT casaszulma therapeuticpotentialoftrpm8channelsincancertreatment
AT albarracinsonial therapeuticpotentialoftrpm8channelsincancertreatment
AT sutachanjhonjairo therapeuticpotentialoftrpm8channelsincancertreatment
AT torresyolimap therapeuticpotentialoftrpm8channelsincancertreatment